ABSTRACT Adding lysolecithin to feed has reportedly improved the performance of broiler chickens. Lysolecithin is generated by phospholipase catalyzed hydrolysis of lecithin. The enzymatic reaction converts various phospholipids into the corresponding lysophospholipids, with lysophosphatidylcholine (LPC) one of the primary products. Here we compared supplementation with a commercial lysolecithin (Lysoforte R ) with comparable levels of highly purified LPC for effects on broilers. Despite no differences in weight gain during the starter period, we discovered a significant increase in average villus length with lysolecithin and an increase in villus width with purified LPC. Highthroughput gene expression microarray analyses revealed many more genes were regulated in the epithelium of the jejunum by lysolecithin compared to purified LPC. The most up-regulated genes and pathways were for collagen, extracellular matrix, and integrins. Staining sections of the jejunum with Picrosirius Red confirmed the increased deposition of collagen fibrils in the villi of broilers fed lysolecithin, but not purified LPC. Thus, lysolecithin elicits gene expression in the intestinal epithelium, leading to enhanced collagen deposition and villus length. Purified LPC alone as a supplement does not mimic these responses. Feed supplementation with lysolecithin triggers changes in the intestinal epithelium with the potential to improve overall gut health and performance.
INTRODUCTION
For about the past 20 yr, lysolecithin produced by enzymatic hydrolysis of soy lecithin has been utilized as a feed additive in broilers and other species (Schwarzer and Adams, 1996) . Some studies reported improved weight gain and feed conversion ratio (FCR) (Zhang et al., 2011; Ahmed et al., 2013; Zampiga et al., 2016) while another did not (Khonyoung et al., 2015) . An increase in apparent metabolizable energy (AME) due to lysolecithin addition (Melegy et al., 2010; Jansen et al., 2015) has provided a rationale for use in rations with reduced nutrient density. This has an economic impact, especially in regions outside the United States where feeds may have lower metabolizable energy (ME). The chemical properties of lysophospholipids as surfactants was the basis for the suggestion that lysolecithin improves fat absorption, in part by serving to emulsify fats and improve their bioavailabil-C 2017 Poultry Science Association Inc.
ity (Schwarzer and Adams, 1996) . Oils, lard, grease, and tallow have been tested as fat sources. Apparently contradictory claims argue for a significant interaction between lysolecithin and fat type in the diet (Jansen et al., 2015) , versus no interaction between fat sources and addition of lysolecithin (Zhang et al., 2011) . Regardless of the type of fat in the feed, the relatively low rates of incorporation of lysolecithin into feed matrices (<1 kg/ton) challenge the concept that the actions depend on emulsification of fats.
An alternative hypothesis is that instead of physical changes in the feed, the various lysophospholipids in lysolecithin elicit physiological responses in the intestine to enhance vigor and improve nutrient absorption. These responses could involve incorporation of the lysophospholipids into the membranes of the intestinal epithelial cells. This has the potential to affect cell-cell junctions and cellular permeability, the clustering and activation of receptors on the surface of cells, or the activity of channels such as ligand-gated ion channels. In addition, responses to lysolecithin could be mediated by the binding of different individual lysophospholipids to receptors that trigger intracellular signaling. There are known G-protein coupled receptors (GPCR) 2889 for lysophosphatidic acid (LPA) called the Endothelial differentiation gene (Edg) family of receptors (Takuwa et al., 2002) , plus an extended family called nonEdg receptors (Yanagida et al., 2013 and Fukushima et al., 2015) . In addition, GPR4 and G2A are GPCR identified for LPC (Murakami et al., 2004; Qiao et al., 2006) , and GPR55 is a receptor for lysophosphatidylinositol (LPI) (Bondarenko et al., 2011; Yamashita et al., 2013) . Signaling in concert through multiple GPCR could give physiological responses that would not be mimicked by any single purified lysophospholipid.
This study was conducted to investigate the molecular mechanisms involved in response to feed supplementation with Lysoforte, a commercial lysolecithin product that is a mixture of lysophospholipids produced from lecithin, and to compare responses to highly purified LPC. We compared control feed to feed supplemented with low and high dose lysolecithin or purified LPC. We did morphometric analyses of the jejunum and ileum sections and employed highthroughput Affymetrix R gene expression microarrays to compare responses of intestinal epithelia, which were validated by qPCR. The results indicate complex physiological responses to feed supplementation with the mixture of lysophospholipids in commercial lysolecithin.
MATERIALS AND METHODS

Animals and Feed
Day-of-hatch Cobb 500 male broilers were obtained from the Cobb hatchery in Wadesboro, NC, and transported to the Virginia Tech Poultry Research Center. One-hundred-twenty-five chicks were weighed, wingbanded, and placed in a room with adjoining floor pens (25/pen), separated by wire fencing. Broilers were individually weighed weekly (d 7, d 14, d 21, and d 28) to assess growth rates but not to generate production data. Tissue samples were collected at d 10 and d 28, but only d 10 samples were analyzed. There were 5 experimental groups. The control group (T1) was provided feed without supplement and was compared to 4 treatment groups: T2 and T3 were supplemented with 93% pure LPC, isolated from lysolecithin by column chromatography, and T4 and T5 were supplemented with Lysoforte R (designated here as lysolecithin), each at 2 different application levels. Lysolecithin and purified LPC were formulated on a carrier of silica and defatted rice bran. The T2 (low dose purified LPC) contained 9.5 g LPC/T supplemented as 500 g/T of LPC formula. T3 (high dose purified LPC) contained 19 g LPC/T supplemented as 1,000 g/T of LPC formula. The T4 (low dose lysolecithin) contained 9.5 g LPC/T supplemented as 500 g/T of lysolecithin. T5 (high dose lysolecithin) contained 19 g LPC/T supplemented as 1,000 g/T of lysolecithin. Lysolecithin and purified LPC were provided by Kemin Industries Inc. (Des Moines, IA). 
Tissue Collection
At d 10, 8 chickens from each treatment group T1 to T5 were randomly chosen for sample analysis. Chickens were killed by cervical dislocation. All animal procedures were approved by the Virginia Tech Institutional Animal Care and Use Committee. Intestinal segments were collected from the jejunum and ileum of all chickens per treatment group for gene expression and morphology analyses. Intestines were rinsed in phosphate buffered saline (PBS) and separated on ice-cold metal trays into jejunum (from the end of the duodenal loop to Meckel's diverticulum) and ileum (from Meckel's diverticulum to the ileocecal junction). An approximately 10 cm piece from the middle of the jejunum and ileum was collected. For morphology analysis, a one cm piece was cut off, rinsed in PBS, and fixed in neutral buffered formalin (10% formaldehyde). For gene expression analysis, the remaining 9 cm piece was slit open longitudinally and rinsed with PBS to remove digesta. The mucosal layer was gently scraped with a glass slide, flash frozen in liquid nitrogen, and stored at −80 C.
Microscopy Analysis
After 24 h in formalin, specimens were transferred to 70% ethanol and shipped to Histo-Scientific Research Labs (Mt. Jackson, VA) for paraffin embedding, sectioning, and hematoxylin and eosin staining. The d 10 samples (total of 40 jejunum and 40 ileum samples) were analyzed and each slide contained 5 tissue slices. Using a Nikon R Eclipse 80i Microscope (Nikon Corporation, Tokyo, Japan) and a DS-Ri1 digital camera, a total of 10 villi was measured per slice. Measurements were taken using NIS-Element AR software. Villus length, villus width, and crypt depth were measured at 10X magnification. The data were statistically analyzed by ANOVA using JMP Pro 13 software (SAS Institute Inc., Cary, NC). The model included the main effects of treatment and intestinal segment and the treatment by segment interaction. Significant effects (P < 0.05) were further evaluated with Tukey's test.
Other paraffin sections were cut and stained with Picrosirius, made of Sirius Red dye, 0.1% in saturated picric acid (Electron Microscopy Sciences, Hatfield, PA). Images were acquired under polarized illumination using an Olympus R BX51 microscope and Olympus DP70 digital camera (Olympus Corporation, Tokyo, Japan). This staining is considered indicative of the relative degree of collagen fiber bundling and crosslinking (Drifka et al., 2016) .
RNA Extraction and Gene Expression Analysis
Mucosal scrapings (approximately 50 mg) from the jejunum and ileum were homogenized with TriReagent (0.5 mL) and total RNA was isolated with Directzol RNA mini prep columns (Zymo Research Co., Irvine, CA). RNA was quantified with a Nanodrop ND 1000 spectrophotometer (Thermo Scientific, Wilmington, DE), and samples were shipped frozen to the University of Virginia for RNA quality and DNA microarray analyses in the Biomolecular Analysis Core facility. RNA quality was assessed with an Agilent BioAnalyzer (Agilent Technologies, Santa Clara, CA), and only samples with a RIN greater than 8.7 were used for microarray analysis. Some tissue samples had to be re-extracted to recover RNA with a RIN > 8.7. Microarray analysis using the chicken genome 1.0 array (Affymetrix, Santa Clara, CA) was performed on the d 10 samples (total of 50 samples: 5 treatments, 2 segments, 5 replicates). The decision to do as many as 5 replicate samples was to increase the number of genes that showed statistically significant differences in expression when comparing groups.
All data processing and analysis were done using R and Bioconductor packages. Affymetrix CEL files were imported using the affy package. Expression intensities were summarized, normalized, and transformed using the Robust Multiarray Average algorithm.
Probesets were annotated using the GEOquery package. For examining differential gene expression, we fit a linear model with empirical-Bayes moderated standard errors using the limma package in R. The dataset has been deposited with NCBI at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc =GSE94622 and assigned accession number GSE94622.
Independent RT-PCR assays were performed on the 5 replicates to verify the results of the microarray analysis. This consisted of a custom set of primers for 93 of the most up-regulated and down-regulated genes from the Affymetrix data (Custom RT 2 Profiler PCR Array, Qiagen, Valencia, CA). The list of genes and GenBank identifiers are in Table 3 . The assay was done in triplicate following the manufacturer's protocol and reaction pre-mix for the control (T1), high dose purified LPC (T3), and high dose lysolecithin (T5) group samples.
We employed bioinformatic tools in the analysis of the Affymetrix array data. ConsensusPathDB (CPDB) from the Max Planck Institute for Molecular Genetics includes a gene set over-representation analysis tool. It takes a user-defined gene list and searches among over-representation sets. A P-value and Q-value are calculated for each set, and the involved genes are represented. In addition, we used STRING (Szklarczyk et al., 2015) , which is a database of protein-protein interactions, to visualize the relationships among selected genes in high dose lysolecithin (T5) vs. control (T1).
RESULTS
This study compared the effects of feed supplementation with purified LPC vs. Lysoforte R , a commercial lysolecithin product produced by enzymatic hydrolysis of soybean lecithin. The mean body weights at d 10 of the chickens were not significantly different among any of the treatment groups (T1 through T5, means ranging from 275.1 to 297.1 g). Villus length, villus width, and crypt depth were measured for the jejunum and ileum at d 10 (Table 2 ). There was a main effect of treatment for villus length and villus width. The villus length in the high dose lysolecithin (T5) group was greater than in the control (T1), low dose purified LPC (T2), and high dose purified LPC (T3) groups. The villus width was greater in the high dose purified LPC (T3) group compared to the control (T1), low dose purified LPC (T2), and high dose lysolecithin (T5) groups. There was a main effect of segment for villus length and crypt depth. Villus length and crypt depth were both greater in the jejunum than in the ileum. Based on the increase in villus length for the high dose lysolecithin (T5) group compared to other groups and the longer villus length and deeper crypts in the jejunum compared to the ileum, we focused subsequent molecular and cellular analyses on the jejunum.
Analysis of gene expression employed Affymetrix microarrays that included probes for 32,773 transcripts, covering 28,000 chicken genes. Data processing included principal component analysis (PCA) of gene expression from all the treatment groups for samples from both the jejunum and ileum (Figure 1 ). The PC1 showed separate clustering of samples from the control and all treatment groups into either the jejunum or ileum. This demonstrated distinctive gene expression profiles for mucosal cells from different segments of the intestine. There were 2 samples from the jejunum (04-1482J and 39-1462J) and 2 from the ileum (47-1441I and 05-1478I) that mapped in the opposite cluster, and, therefore, these were excluded from further analyses. We speculate that this discrepancy may be due to some natural variation in intestinal gene expression among chickens, or a sampling error. Meckel's diverticulum, which is the point at which the yolk stalk enters the intestine, is typically used as a convenient marker to separate the jejunum and ileum, but it is not associated with any clear morphological differences in the intestine. Thus, in the cases of chickens 1441, 1462, 1478, and 1482, jejunum and ileum samples may show similar gene expression patterns, especially at an early age of d 10 post hatch. Alternatively, the jejunum and ileum samples may have been inadvertently switched. We were not able to discern whether biological variation or sampling error was the cause of the discrepancy in the PCA. Comparing gene expression for only the jejunum samples revealed the largest number of differences for high dose purified LPC (T3) and high dose lysolecithin (T5) groups compared to the control (T1). Volcano plots were used to compare the changes in gene expression (Figure 2 ). Using statistical cutoffs of |log 2 FC| > 1 and adjusted P < 0.1 (that differs from raw P values), we found that high dose purified LPC (T3) upregulated many more genes than were down-regulated (54 vs. 5, green dots, Figure 2A ). In contrast, high dose lysolecithin (T5) significantly up-regulated about the same number of genes as were down-regulated Volcano plots of gene expression in the jejunum in response to feed supplementation. Expression of genes based on Affymetrix analyses are plotted based on log 2 fold change (FC) vs. -log10 raw P-value. Genes more than 2-fold increased or decreased appear in gold, those with adjusted P-values < 0.1 appear red, and those exceeding both cutoffs are green. The differential expression analysis was for high dose purified LPC (T3) vs. control (T1) (A) and for high dose lysolecithin (T5) vs. control (T1) (B).
( Figure 2B ), and there were substantially more genes affected, both up-regulated and down-regulated, compared to purified LPC (T3) (compare Figure 2A and  B) . Furthermore, expression changes were statistically significant for many more genes with lysolecithin vs. purified LPC, when including changes that were less than log 2 FC = 1 (red dots, Figure 2A, B) . The volcano plots displayed on the same scale demonstrate supplementation with purified LPC and lysolecithin produced distinctive gene expression signatures in the jejunum.
We used qPCR to validate and quantify changes in several dozen genes most affected in Affymetrix analyses, comparing the high dose purified LPC (T3) and high dose lysolecithin (T5) groups relative to the control (T1) group. These genes included multiple collagens, plus laminins and proteoglycan components of the extracellular matrix (Table 3) . As shown in Figure 3A , lysolecithin supplementation stimulated expression of 18 of these genes greater than 10-fold in the jejunum, plotted in rank order. These same genes (Table 4) also were induced by purified LPC supplementation, but all at less than a 10-fold increase in expression and not in the same rank order. These results with qPCR validated the identification of up-regulated genes in high dose purified LPC (T3) and high dose lysolecithin (T5) groups relative to the control (T1), and reinforced the conclusion that the pattern of gene expression in the jejunum was different for feed supplementation with purified LPC compared to lysolecithin. The CPDB from the Max Planck Institute is an online bioinformatics algorithm we used to identify pathways up-regulated and down-regulated by lysolecithin treatment. The pathways most affected in high dose lysolecithin (T5) vs. the control (T1) in terms of statistical significance ( Figure 3B ) were those involving extracellular matrix components and the cellular receptors for these components (i.e., integrins).
Gene set enrichment analysis (GSEA) uses the fold change from the microarray analysis of all genes to compute a normalized enrichment score (NES) for gene groupings, based on known Gene Ontology (GO) or KEGG pathways. We found that 230 of the total 913 gene sets were up-regulated with P < 0.05. The top 6 gene sets were up-regulated by both high dose purified LPC as well as high dose lysolecithin, pointing out that some responses were common for these treatments. These 6 gene sets are involved in expression of integrins, collagen, and extracellular matrix formation ( Figure 3C ). We compiled a select list of 24 genes that positively contributed to the NES values for 2 or more of these top 6 GSEA pathways. These 24 genes were mapped into a signaling network using the STRING tool (Figure 4) . This network showed an outer ring of extracellular matrix components, with multiple collagens plus laminins converging on a hub of integrins that are strongly linked to intracellular signaling involving the Tyr kinases Src and PTK2.
The dominance of collagens among the most induced genes in the jejunum response to lysolecithin supplementation led us to hypothesize there would be increased deposition of collagen in the tissue. To test this, we stained transverse sections of the jejunum from the control (T1) and high dose lysolecithin (T5) treated birds with the collagen-specific reagent Picrosirius Red (Figure 5 ). Viewing under white light illumination allows for visualization of the muscularis externa at the circumference of the intestine, and the villi in the lumen of the intestine ( Figure 5 , right hand panels, arrows). When viewed with polarized light illumination, the collagen fibrils appear yellow and green (Figure 5, left hand panels) . In addition to the very bright Figure 4 . STRING schematic of genes up-regulated in chicken jejunum by lysolecithin. Genes that appeared in at least 2 of the 6 top GSEA (Gene set enrichment analysis) pathways ( Figure 3C ) were used to populate the STRING visualization tool, creating this network map. As described in Results, a cluster of various integrin receptors (ITG) for extracellular matrix is centered inside an outer ring representing genes for multiple types of collagens (COL), fibronectin (FN1), and laminins (LAM) A and B subtypes. The integrins are linked to intracellular signaling by Tyr kinases SRC and PTK2.
appearance of the surrounding muscle layers, there was staining of collagen in the individual villi. The high dose lysolecithin (T5) samples had more and longer strands of collagen staining in the villi compared to the controls (T1). These results show increased density of collagen fibrils in the villi of the jejunum that correspond to the up-regulation of genes in response to lysolecithin supplementation of feed for 10 days.
DISCUSSION
This study discovered extensive changes of gene expression in the jejunum of broilers in response to feed supplementation with Lysoforte, a commercial preparation of lysolecithin. The response involved increased and decreased expression of dozens of genes, and bioinformatic analyses identified pathways for collagen, extracellular matrix, and integrins as most significantly up-regulated. This pattern of gene expression corresponded to increased villus length as well as enhanced deposition of collagen in the villi. We suggest that the lysolecithin-induced changes of the intestinal epithelium are responsible for previous independent reports of improved nutrient uptake, energy utilization, and better performance. Further, lysolecithin addition to feed promotes responses in the intestine that may preserve health of production broilers in the face of environmental challenges such as heat stress and infection (Song et al., 2014) .
The ultrastructure of the intestinal villi has been extensively studied in rats (Hosoyamada and Sakai, 2007) . Villus-axial smooth muscle cells (villus-axis SM) are attached to myofibroblasts at the apex of the villus and to collagen fibrils anchored to the connective tissue located just above the muscle layer (muscularis mucosae) of the intestinal wall. The collagen fibrils serve as microtendons to transmit the mechanical force of the villus-axis SM. The more prominent collagen fibrils in the villi that we observed correspond to the lengthening of the villi. The intestinal villi are covered with a single layer of absorptive and secretory cells in mammals (Carulli et al., 2014) , which is presumably the same structure in chickens. Thus, longer villi would provide an increased absorptive area for the uptake of nutrients, which would also increase the interstitial hydrostatic pressure (Hosoyamada and Sakai, 2005 ). An increase in tensile strength of the villi through increased deposition of collagen fibrils would be one way to counteract the increased hydrostatic force.
It was of interest to us that neither the pattern of gene expression nor the increased length of villi in the jejunum was elicited by comparable doses of purified LPC instead of lysolecithin. This supports the concept that multiple lysophospholipids (or other chemical constituents) in lysolecithin contribute to its biological actions. We speculate that the engagement of several different GPCR for the various lysophospholipids create a combinatorial response. This concept is at odds with the proposal that LPC is the dominant active ingredient in lysolecithin. That idea is based on the fact that lecithin, the starting material for manufacture of lysolecithin, is nominally phosphatidylcholine, and enzymatic hydrolysis would be expected to primarily produce LPC as a product. However, chemical analysis of soybean lecithin reveals an admixture of various phospholipids that are substrates for phospholipases to generate lysophospholipids such as lysophosphatidylethanolamine (LPE), LPI, and LPA in addition to LPC (Scholfield, 1981) . Furthermore, lecithins prepared from different plant sources do not have the same phospholipid composition, so using alternative sources for preparation of lysophospholipids would generate different mixtures of products. In addition, using different phospholipases to hydrolyze lecithins would generate a different set of lysophospholipids. Deconvolving such mixtures and finding the right composition of active components to stimulate a particular gene expression profile in the broiler intestine would be a challenging task.
Our results point to a new mechanism of action for a feed additive in use for more than two decades. Such a mechanism might well apply to other monogastric species, consistent with positive results in field trials. In our view, feed additives such as lysolecithin act in parallel with feed ingredients in an overall nutrigenomic response that can be managed to improve the health and performance of production animals.
